JN Lorenz, VM Lasko, ML Nieman… - … of Physiology-Renal …, 2011 - Am Physiological Soc ... Temporal analysis of signaling pathways 371 activated in a murine model of two-kidney, one-clip hypertension. Am J Physiol Renal Physiol 372 297: F1055-1068, 2009. 373 7. Collis MG and Vanhoutte PM. Increased renalvascular reactivity to angiotensin II but 374 ... All 2 versions
[HTML] from nih.govLC Matavelli, J Huang… - Hypertension, 2011 - Am Heart Assoc ... on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:861–869.[CrossRef][Medline] [Order article via Infotrieve]. 36. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: ... Cited by 1 - Related articles - All 5 versions
J Gao, J Bellien, E Gomez, JP Henry… - … of Hypertension, 2011 - journals.lww.com ... derived hyperpolarizing factors (EDHFs) [7–9] . Of importance, angiotensin II induces an upregulation of sEH expression in renal and vascular tissues, leading to a reduction in EETs availability [10,11] . This mechanism contributes to the development of hypertension in various ... Related articles - All 4 versions
I Baumgartner… - European Heart Journal, 2011 - Eur Soc Cardiology ... between study populations. Advances in vascular imaging and more liberal advice to undergo PTRA in patients with renal FMD and hypertension may explain the disappointing blood pressure control in more recent publications. ... Cited by 1 - Related articles - All 3 versions
VH Urbieta-Caceres, XY Zhu, ME Gibson… - … of Hypertension, 2011 - nature.com ...Hypertension (HTN) may lead to left ventricular hypertrophy and vascular dysfunction, which are independent factors for adverse cardiovascular outcomes. We hypothesized that decreased blood pressure by percutaneous transluminal renal angioplasty (PTRA) would improve ... Related articles - All 3 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
